Novartis Acquires DTx Pharma in Potential $1B Deal
18 Jul 2023 //
BIOSPACE
DTx Pharma Receives FDA Orphan Drug Designation for DTx-1252
07 Jun 2023 //
PR NEWSWIRE
DTx Pharma Appoints Michael Huang, MD as Chief Medical Officer
31 May 2022 //
BUSINESSWIRE
DTx Pharma Announces Appointment of Kathie M. Bishop to its Board of Directors
02 May 2022 //
BUSINESSWIRE
DTx Pharma to Participate in the 2021 BMO BioPharma Day
16 Jun 2021 //
BUSINESSWIRE
DTx Pharma Appoints Jill Howe as Chief Financial Officer
07 Jun 2021 //
BUSINESSWIRE
DTx Pharma Completes $100M Series B Financing to Advance its FALCON™
01 Mar 2021 //
PRNEWSWIRE
DTx Pharma to Present at Several Upcoming Virtual Events
25 Nov 2020 //
PRNEWSWIRE